Annovis Bio Inc. (ANVS) Fundamentals

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
SHARE INFORMATION
Market Cap$ 100,252,974
Shares Outstanding8,163,923
Float5,638,000
Percent Float69.06%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.90
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions70
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months48,396
Institutional Holdings Percent17.8%
Institutional Sold Previous 3 Months113,871
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent32.1
Insider Sold Previous 3 Months-
Insider Shares Owned2,621,623
TRADING INFO
52 Week High$ 43.37
52 Week Low$ 8.39
52 Week High Change$ -69.71
21 Day Moving Average$ 12.0886
21 Day Extended Moving Average$ 11.8724
50 Day Moving Average$ 11.7836
50 Day Extended Moving Average$ 11.8515
200 Day Moving Average$ 15.594
200 Day Extended Moving Average$ 16.8701
10 Day Average Volume26,799
20 Day Average Volume38,047
30 Day Average Volume111,037
50 Day Average Volume88,053
Alpha0.072245
Beta1.6221
Standard Deviation0.437761
R20.050061
7 Day Price Change$ 1.25
7 Day Percent Change11.33%
21 Day Price Change$ -0.66
21 Day Percent Change-5.1%
30 Day Price Change$ -2.33
30 Day Percent Change-15.95%
Month to Date Price Change$ 0.78
Month to Date Percent Change6.78%
Quarter to Date Price Change$ 0.94
Quarter to Date Percent Change8.29%
180 Day Price Change$ -3.22
180 Day Percent Change-20.77%
200 Day Price Change$ -0.76
200 Day Percent Change-5.83%
Year to Date Price Change$ -5.30
Year to Date Percent Change-30.15%

Annovis Bio Inc. (ANVS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.30
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio34.50
Leverage Ratio1.00
Quick Ratio34.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-5.60
Enterprise Value$ 55,379,877
Price to Sales0.00
Price to Free Cash-15.00
PE High Last 5 Years0.00
Price To Book2.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-70.23
Return on Equity-74.44
Return on Capital-74.19

Annovis Bio Inc. (ANVS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorWithumSmith+Brown, PC
CEOMaria Maccecchini
Emplyoees3
Last AuditUQ
CIK0001477845
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address1055 Westlakes Drive
Suite 300
Berwyn, PA 19312
Websitehttps://www.annovisbio.com
Facsimile+1 610 727-4001
Telephone+1 610 727-3913
Email-


Your Recent History
NYSE
ANVS
Annovis Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.